News

Siemens Medical Solutions has released the 4.0 ACUSON Antares ultrasound system, premium edition. Antares 4.0 will ...

Home September 26, 2006
Home
News

Johnson & Johnson has filed a $5.5 billion lawsuit against Guidant Corp. in U.S. District Court in New York, claiming that Guidant leaked confidential information to Abbott Laboratories to secure a crucial component of the deal with Boston Scientific, reports Modernhealthcare.com.

Home September 26, 2006
Home
Feature | Kim Phelan

Two of the six astronauts from the shuttle mission Atlantis became part of an ongoing cardiovascular study at NASA about ...

Home September 25, 2006
Home
News

Japanese radiologist Katsumi Nakamura, M.D., of Tobata Kyoritsu Hospital, received first place honors for his research in the area of non-contrast magnetic resonance angiography (MRA) imaging at the 14th annual International Society for Magnetic Resonance in Medicine (ISMRM) Scientific Meeting & Exhibition.

Home September 18, 2006
Home
News

Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.

Home September 18, 2006
Home
News

The Heartlab cardiovascular solution for cardiology image and information management received the top rating for Cardiology PACS (Picture Archiving and Communication Systems) in the KLAS Mid-Year Report (June 2006, www.healthcomputing.com).

Home September 18, 2006
Home
News

Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.

Home September 18, 2006
Home
News

GE Healthcare and Volcano Corp. have announced FDA 510(k) clearance for the integration of Volcano’s intravascular ultrasound imaging (IVUS) capabilities onto the best-of-class Innova all-digital X-ray cath lab imaging system

Home September 18, 2006
Home
News

The FDA has approved Medtronic’s Adapta portfolio of fully automatic pacemakers. The system provides physiologic pacing ...

Home September 18, 2006
Home
News

New SPECT/CT, cardiovascular IT and PET/CT technologies were on display by Philips Medical Systems at the American Society of Nuclear Cardiology (ASNC) annual meeting in Montreal.

Home September 18, 2006
Home
News

Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the deadly, lipid-rich coronary plaque that ruptures without warning or symptoms and possibly the source of most heart attacks.

Home September 18, 2006
Home
News

Siemens completed its acquisition of Diagnostic Products Corp. (DPC) in late July, marking a significant milestone for Siemens as it enters the in-vitro diagnostics (IVD) market. Together with DPC, Siemens Medical Solutions says it will become the first full service diagnostics company.

Home September 18, 2006
Home
News

Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.

Home September 18, 2006
Home
Feature | Ryan Hiett

It may seem like a simple concept, but the importance of properly controlled patient temperature is still surprising ...

Home September 12, 2006
Home
Case Study | Kishor N. Vora, MD., Interventional Cardiologist, Owensboro Medical Health System, Owensboro, Kentuc

Targeted Renal Therapy (TRT) with the Benephit CV Infusion System from FlowMedica Inc. is an alternative to systemic intravenous (IV) infusion of medications to address kidney dysfunction related to a number of conditions. TRT is a novel technology that enables the infusion of medications and other therapeutic agents directly into the kidneys via the renal arteries.

Home August 29, 2006
Home
Subscribe Now